Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced ...

Sensus Healthcare to Report Fourth Quarter and Full Year 2025 Financial Results and Hold Business Update Conference Call on February 12, 2026 Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device ...

Proprietary cloud-based software and add-on solution designed to provide current and future SRT-100 users with enhanced workflow, operating intelligence and clinical utility Creates a scalable, ...

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological ...

Good afternoon, and welcome to the Sensus Healthcare Fourth Quarter and Full Year 2025 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded. I would now ...

BOCA RATON, Fla.--(BUSINESS WIRE)-- Sensus Healthcare, Inc. (SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for ...

Sensus Healthcare (NASDAQ:SRTS) is preparing to release its quarterly earnings on Thursday, 2026-02-12. Here's a brief overview of what investors should keep in mind before the announcement. Analysts ...

Thursday, November 6, 2025 at 4:30 p.m. ET President and General Counsel Michael Sardano said, "the goal of our lobbying efforts and the outcome of these new CPT codes is that the gap will now narrow ...

Sensus Healthcare Inc. advanced stock charts by Barron's. View SRTS historical stock data and compare to other stocks, and exchanges.

BOCA RATON, Fla.--(BUSINESS WIRE)-- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments ...

Image source: The Motley Fool. Management implemented a business model adjustment by eliminating reliance on the previously dominant customer and now forecasts top-line growth through a more ...